首页
400-620-6333
CD抗原
选项
-
Recombinant Human NCAM-1/CD56 Protein
- 种属: 人(Human)
- Accession #: P13591
- 表达系统: CHO
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: Testing in progress
-
Recombinant Human CD68 Protein
- 种属: 人(Human)
- Accession #: P34810
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
-
Recombinant Canine CD64 Protein
- 种属: 狗(Canine)
- Accession #: Q7YQJ5
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
-
Recombinant Bovine CD4 Protein
- 种属: 牛(Bovine)
- Accession #: F1MJK4
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: Measured by the ability of the immobilized protein to support the adhesion of NIH‑3T3 mouse embryonic fibroblast cells.The ED50for this effect is 0.1-0.5 μg/mL after a 1 hour incubation at37 °C.Optimal dilutions should be determined by each laboratory for each application.
-
Recombinant Feline CD56 Protein
- 种属: 猫(Feline)
- Accession #: Q5G7G8
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
-
Recombinant Human CD24 Protein
- 种属: 人(Human)
- Accession #: P25063
- 表达系统: HEK293
- 蛋白标签: C-hFc
- 内毒素水平: <1.0 EU/μg
- 生物活性: Testing in progress
-
Recombinant Human Siglec-2/CD22 Protein
- 种属: 人(Human)
- Accession #: P20273
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind Inotuzumab (anti-CD22) (Ab176429) with the EC50 of 20.1 ng/mL. Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind bind Epratuzumab (anti-CD22) (Ab175532) with the EC50 of 207.0 ng/mL.
-
Recombinant Human CD72 Protein
- 种属: 人(Human)
- Accession #: P21854
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: Testing in progress
-
Recombinant Human gp130 Protein
- 种属: 人(Human)
- Accession #: P40189
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: Testing in progress
-
Recombinant Human CD79B Protein
- 种属: 人(Human)
- Accession #: P40259
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: 1. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL. 2. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) with the EC50 of 51.95 ng/mL.
-
Recombinant Mouse NKp46/NCR1 Protein
- 种属: 小鼠(Mouse)
- Accession #: Q8C567
- 表达系统: HEK293
- 蛋白标签: C-hFc & His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Mouse NKp46/NCR1 Fc Chimera is immobilized at 0.5 μg/mL (100 μL/well), the concentration of Recombinant Human Vimentin that produces 50% of the optimal binding response is found to be approximately 30-150 ng/mL.
-
Recombinant Human CD14 Protein
- 种属: 人(Human)
- Accession #: P08571
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <1.0 EU/μg
- 生物活性: Immobilized Recombinant Human CD14 Protein (rp169573) at 1.0 μg/mL can bind Recombinant CD14 Antibody (Ab006698) with the EC50 of 5.7 ng/mL.
